Kamat - Figure 17
Papillary Recurrence of Bladder Cancer after Induction BCG Therapy
FIG. 17: The grade of the recurrence is different from the stage of the tumor. If the patient has a recurrence at the first evaluation with a Ta or T1 lesion, they need to be followed with the same close vigilance.[18] However, if these patients have a low-grade recurrence, this can be considered a non-event, as far as BCG induction failure is concerned, and they can continue on maintenance therapy for the short term.
References
[18]
Mmeje CO, Guo CC, Shah JB, et al. Papillary recurrence of bladder cancer at first evaluation after induction bacillus Calmette-Guérin therapy: Implication for clinical trial design. Eur Urol. 2016;70:778−85 http://dx.doi.org/10.1016/j.eururo.2016.02.031
